206 related articles for article (PubMed ID: 1834312)
1. A post-mortem study on striatal dopamine receptors in Parkinson's disease.
Rinne JO; Laihinen A; Lönnberg P; Marjamäki P; Rinne UK
Brain Res; 1991 Aug; 556(1):117-22. PubMed ID: 1834312
[TBL] [Abstract][Full Text] [Related]
2. D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
Pierot L; Desnos C; Blin J; Raisman R; Scherman D; Javoy-Agid F; Ruberg M; Agid Y
J Neurol Sci; 1988 Sep; 86(2-3):291-306. PubMed ID: 2975699
[TBL] [Abstract][Full Text] [Related]
3. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
Mattila PM; Röyttä M; Lönnberg P; Marjamäki P; Helenius H; Rinne JO
Acta Neuropathol; 2001 Aug; 102(2):160-6. PubMed ID: 11563631
[TBL] [Abstract][Full Text] [Related]
4. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
5. L-dopa reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum.
Guttman M; Seeman P
J Neural Transm; 1985; 64(2):93-103. PubMed ID: 2934514
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent decline in human brain dopamine D1 and D2 receptors.
Rinne JO; Lönnberg P; Marjamäki P
Brain Res; 1990 Feb; 508(2):349-52. PubMed ID: 2407314
[TBL] [Abstract][Full Text] [Related]
7. Impaired ontogeny of striatal dopamine D1 and D2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol.
Kostrzewa RM; Saleh MI
Brain Res Dev Brain Res; 1989 Jan; 45(1):95-101. PubMed ID: 2645067
[TBL] [Abstract][Full Text] [Related]
8. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride.
Rinne JO; Laihinen A; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Oikonen V; Rinne UK
J Neurol Sci; 1995 Oct; 132(2):156-61. PubMed ID: 8543941
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
[TBL] [Abstract][Full Text] [Related]
10. In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias.
Turjanski N; Lees AJ; Brooks DJ
Neurology; 1997 Sep; 49(3):717-23. PubMed ID: 9305330
[TBL] [Abstract][Full Text] [Related]
11. D1 and D2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis).
Madras BK; Fahey MA; Canfield DR; Spealman RD
J Neurochem; 1988 Sep; 51(3):934-43. PubMed ID: 2970527
[TBL] [Abstract][Full Text] [Related]
12. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
Joyce JN; Lexow N; Bird E; Winokur A
Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
[TBL] [Abstract][Full Text] [Related]
13. Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors.
Srivastava LK; Mishra RK
Biochem Int; 1990; 21(4):705-14. PubMed ID: 2241996
[TBL] [Abstract][Full Text] [Related]
14. Ethanol administration does not alter dopamine D1 and D2 receptor characteristics in rat brain.
Hietala J; Salonen I; Lappalainen J; Syvälahti E
Neurosci Lett; 1990 Jan; 108(3):289-94. PubMed ID: 2137566
[TBL] [Abstract][Full Text] [Related]
15. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
16. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
Beckstead RM; Wooten GF; Trugman JM
J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
[TBL] [Abstract][Full Text] [Related]
17. Localized alterations of dopamine receptor binding in rat brain by repeated electroconvulsive shock: an autoradiographic study.
Barkai AI; Durkin M; Nelson HD
Brain Res; 1990 Oct; 529(1-2):208-13. PubMed ID: 2149297
[TBL] [Abstract][Full Text] [Related]
18. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation.
Rico AJ; Dopeso-Reyes IG; Martínez-Pinilla E; Sucunza D; Pignataro D; Roda E; Marín-Ramos D; Labandeira-García JL; George SR; Franco R; Lanciego JL
Brain Struct Funct; 2017 May; 222(4):1767-1784. PubMed ID: 27612857
[TBL] [Abstract][Full Text] [Related]
20. Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: a quantitative autoradiographic study.
Przedborski S; Kostic V; Jackson-Lewis V; Cadet JL; Burke RE
J Neurochem; 1991 Dec; 57(6):1951-61. PubMed ID: 1834800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
